The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Neuroinflammation, Neurodegeneration, and Depression
Open accessAbstract
Neurodegeneration and depression are two common co-morbid conditions, particularly within the aging population. Research has linked neuroinflammation as a major contributing factor to both of these diseases. The key to neuroinflammation effects on neurodegeneration and depression appears to lie within the dysregulation of the control and release of pro- and anti-inflammatory cytokines. This can come from an internal or external insult to the system, or from changes in the individual due to aging that culminate in immune dysregulation. The need to reduce neuroinflammation has led to extensive research into neuroprotectants. We discuss the efficacy found with nicotine, alcohol, resveratrol, curcumin, and ketamine. Our main focus will be on what research tells us about the connections between neuroinflammation, neurodegeneration, and depression, and the hope that neuroprotectants research gives people suffering from neurodegeneration and depression stemming from neuroinflammation. We will conclude by making suggestions for future research in this area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 2×
“Resveratrol has been shown to impedes cancer progression at various stages (Jang et al. 1997), reduce cardiovascular disease (Bradamante et al.”
BackgroundA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 7×
“, IL-6 and IL-1b) can remain elevated and induce symptoms of a syndrome termed ‘‘sickness behavior’’ (Kent et al. 1992; Qin et al. 2007).”
BackgroundInfluentialMcEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Aggarwal, B. B., & Harikumar, K. B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 1,716
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Aloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280
Steptoe, A., Hamer, M., & Chida, Y. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.03.011 · Cited by 1,278
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
Steensberg, A., Fischer, C. P., Keller, C., Møller, K., & Pedersen, B. K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2003 · Cited by 1,135
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Anti-tumour and antioxidant activity of natural curcuminoids
Ruby, A. J., Kuttan, G., Dinesh Babu, K., Rajasekharan, K. N., & Kuttan, R. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03827-j · Cited by 1,067
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Sickness behavior as a new target for drug development
Kent, S., Bluthé, R.-M., Kelley, K. W., & Dantzer, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90012-u · Cited by 863
IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress
Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862
Antioxidant activity of curcumin and related compounds
Sharma, O. P. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90421-4 · Cited by 851
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., & Cellerino, A. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.038 · Cited by 784
Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., Kenis, G., Bosmans, E., De Meester, I., Benoy, I., Neels, H., et al. (1998) · Cytokine · doi:10.1006/cyto.1997.0290 · Cited by 772 · cited 1×
“Maes et al. (1998) were the first to show that psychological stress in humans induces an inflammatory response through production of pro-inflammatory cytokines, such as IFN-c and TNF-a.”
BackgroundCotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Goshen, I., Kreisel, T., Ben-Menachem-Zidon, O., Licht, T., Weidenfeld, J., Ben-Hur, T., & Yirmiya, R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002055 · Cited by 762
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Dysregulation of in vitro cytokine production by monocytes during sepsis.
Munoz, C., Carlet, J., Fitting, C., Misset, B., Blériot, J. P., & Cavaillon, J. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115493 · Cited by 754
Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., Limtrakul, P., Badmaev, V., & Aggarwal, B. B. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm123 · Cited by 687
The role of microglia and macrophages in the pathophysiology of the CNS
Stollg, G., & Jander, S. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00083-5 · Cited by 683
Cytokines and cognition–the case for a head-to-toe inflammatory paradigm.
Wilson, C. J., Finch, C. E., & Cohen, H. J. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50619.x · Cited by 637
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Glial Loss in the Prefrontal Cortex Is Sufficient to Induce Depressive-like Behaviors
Banasr, M., & Duman, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.008 · Cited by 602
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Cardiovascular Protective Effects of Resveratrol
Bradamante, S., Barenghi, L., & Villa, A. (2004) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2004.tb00139.x · Cited by 528
Changes in cytokines and neurotrophins in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6301-6_19 · Cited by 510
Quantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex
Harrison, N. L., & Simmonds, M. A. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb12922.x · Cited by 485
Amygdala core nuclei volumes are decreased in recurrent major depression
Sheline, Y. I., Gado, M. H., & Price, J. L. (1998) · NeuroReport · doi:10.1097/00001756-199806220-00021 · Cited by 472 · cited 2×
“in key brain regions such as prefrontal cortex and amygdala of patients with mood disorders causally links select reduction in brain volume to depression (Cotter et al. 2001; Rajkowska 2002; Rosso et al. 2005; Sheline et al. 1998).”
BackgroundThe vagus nerve and the nicotinic anti-inflammatory pathway
Ulloa, L. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1797 · Cited by 468
Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat
Nguyen, K. T., Deak, T., Owens, S. M., Kohno, T., Fleshner, M., Watkins, L. R., & Maier, S. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02239.1998 · Cited by 460
ABE, Y., HASHIMOTO, S., & HORIE, T. (1999) · Pharmacological Research · doi:10.1006/phrs.1998.0404 · Cited by 452
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443
De, R., Kundu, P., Swarnakar, S., Ramamurthy, T., Chowdhury, A., Nair, G. B., & Mukhopadhyay, A. K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-08 · Cited by 432
Czéh, B., & Lucassen, P. J. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0728-0 · Cited by 419
Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation
Roubenoff, R., Harris, T. B., Abad, L. W., Wilson, P. W. F., Dallal, G. E., & Dinarello, C. A. (1998) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/53a.1.m20 · Cited by 418 · cited 2×
“For example, aging patients without neurological diseases show a progressive increase in the expression of IL-1 and microglia activation (Roubenoff et al. 1998; Wilson et al. 2002), but this increase is still less than in patients with Alzheimer’s disease (Griffin et al.”
BackgroundKihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415
Zou, J. Y., & Crews, F. T. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.014 · Cited by 410
A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387
Smoking cessation and the course of major depression: A follow-up study
Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05064-9 · Cited by 370
Sinha, K., Chaudhary, G., & Kumar Gupta, Y. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 354
Curry Consumption and Cognitive Function in the Elderly
Ng, T.-P., Chiam, P.-C., Lee, T., Chua, H.-C., Lim, L., & Kua, E.-H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj267 · Cited by 353
Khairova, R. A., Machado-Vieira, R., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709009924 · Cited by 350
Decreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342
Antidepressant activity of curcumin: involvement of serotonin and dopamine system
Kulkarni, S. K., Bhutani, M. K., & Bishnoi, M. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1300-y · Cited by 337
Sandur, S. K., Ichikawa, H., Pandey, M. K., Kunnumakkara, A. B., Sung, B., Sethi, G., & Aggarwal, B. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.009 · Cited by 331
Manji, H. K., MD, Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Csaki, C., Mobasheri, A., & Shakibaei, M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2850 · Cited by 318
The Society for Neuroscience 1995 annual meeting.
Hu, R. J. (1996) · PubMed · Cited by 316
The immune system and memory consolidation: a role for the cytokine IL-1β
Rachal Pugh, C., Fleshner, M., Watkins, L. R., Maier, S. F., & Rudy, J. W. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00048-8 · Cited by 314
Buckingham, S. D., Jones, A. K., Brown, L. A., & Sattelle, D. B. (2009) · Pharmacological Reviews · doi:10.1124/pr.108.000562 · Cited by 308
Zunszain, P. A., Hepgul, N., & Pariante, C. M. (2012) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2012_211 · Cited by 303
The monocyte-T-lymphocyte hypothesis of major depression
Maes, M., Smith, R., & Simon, S. (1995) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)00066-j · Cited by 299
Depressive-like behavior induced by tumor necrosis factor-α in mice
Kaster, M. P., Gadotti, V. M., Calixto, J. B., Santos, A. R. S., & Rodrigues, A. L. S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.018 · Cited by 294
Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens
Wang, Y., Lu, Z., Wu, H., & Lv, F. (2009) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2009.09.001 · Cited by 294
Cytokines mediated inflammation and decreased neurogenesis in animal models of depression
Song, C., & Wang, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.020 · Cited by 291
Incidence of Alzheimer’s disease in a rural community in India: The Indo–US Study
Chandra, V., Pandav, R., Dodge, H. H., Johnston, J. M., Belle, S. H., DeKosky, S. T., & Ganguli, M. (2001) · Neurology · doi:10.1212/wnl.57.6.985 · Cited by 284
IL-6: Insights into Novel Biological Activities
Barton, B. E. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4420 · Cited by 269 · cited 2×
“For example, IL-6 has acute proinflammatory action (Hurst et al. 2001; Barton et al. 1996), but can also act to attenuate or down-regulate synthesis of other pro-inflammatory cytokines (e.g., Interferon-gamma (IFN-c), IL-1, and TNF-a: Barton 1997; Libert et al. 1994; Xing et al. 1998).”
BackgroundDepression and Stages of Huntington's Disease
Paulsen, J. S. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.4.496 · Cited by 267
Xu, Y., Ku, B.-S., Yao, H.-Y., Lin, Y.-H., Ma, X., Zhang, Y.-H., & Li, X.-J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.009 · Cited by 265
Li, S., Wang, C., Wang, M., Li, W., Matsumoto, K., & Tang, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.12.027 · Cited by 263
Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain
Zou, X., Patterson, T. A., Divine, R. L., Sadovova, N., Zhang, X., Hanig, J. P., Paule, M. G., Slikker, W., & Wang, C. (2009) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2009.06.010 · Cited by 260
Curcumin Modulates Nuclear Factor κB (NF-κB)-mediated Inflammation in Human Tenocytes in Vitro
Buhrmann, C., Mobasheri, A., Busch, F., Aldinger, C., Stahlmann, R., Montaseri, A., & Shakibaei, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256180 · Cited by 260
Barrientos, R. M., Higgins, E. A., Sprunger, D. B., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00043-8 · Cited by 257
Major depression following smoking cessation
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.2.263 · Cited by 250
Bhutani, M. K., Bishnoi, M., & Kulkarni, S. K. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.007 · Cited by 248
Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation
Pugh, C. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00098-4 · Cited by 246
Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro
Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y., & Wu, J. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.77 · Cited by 244
The effects of curcumin on depressive-like behaviors in mice
Xu, Y., Ku, B.-S., Yao, H.-Y., Lin, Y.-H., Ma, X., Zhang, Y.-H., & Li, X.-J. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.002 · Cited by 244
Amygdala and hippocampus volumes in pediatric major depression
Rosso, I. M., Cintron, C. M., Steingard, R. J., Renshaw, P. F., Young, A. D., & Yurgelun-Todd, D. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.027 · Cited by 240
Α Review on the Acute Phase Response in Major Depression
Maes, M. (1993) · Reviews in the Neurosciences · doi:10.1515/revneuro.1993.4.4.407 · Cited by 239
The psychoneuroimmunology of depression
Leonard, B. E., & Myint, A. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1011 · Cited by 236
Collins, M. A., Neafsey, E. J., Mukamal, K. J., Gray, M. O., Parks, D. A., Das, D. K., & Korthuis, R. J. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00828.x · Cited by 235 · cited 1×
“Epidemiological studies show trends that light to moderate drinkers have reduced risk of dementia and cognitive decline in comparison to non-drinkers (reviewed Collins et al. 2009).”
BackgroundNonmotor manifestations of Parkinson's disease
Simuni, T., & Sethi, K. (2009) · Annals of Neurology · doi:10.1002/ana.21472 · Cited by 235
Curcumin prevents adriamycin nephrotoxicity in rats
Venkatesan, N., Punithavathi, D., & Arumugam, V. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703067 · Cited by 231
Tobacco Consumption and Mortality from Cancer and Other Diseases
Dorn, H. F. (1959) · Public Health Reports (1896-1970) · doi:10.2307/4590516 · Cited by 228
Stress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225
Therapeutic potential of resveratrol in Alzheimer's disease
Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., & Marambaud, P. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s6 · Cited by 224
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215
Picciotto, M. (2008) · Frontiers in Bioscience · doi:10.2741/2695 · Cited by 212
Antihepatotoxic Principles of Curcuma longa Rhizomes
Kiso, Y., Suzuki, Y., Watanabe, N., Oshima, Y., & Hikino, H. (1983) · Planta Medica · doi:10.1055/s-2007-969845 · Cited by 211
Antidepressant effects of nicotine in an animal model of depression
Tizabi, Y., Overstreet, D. H., Rezvani, A. H., Louis, V. A., Clark Jr, E., Janowsky, D. S., & Kling, M. A. (1999) · Psychopharmacology · doi:10.1007/s002130050879 · Cited by 209 · cited 1×
“In animal model studies, it is clear that nicotine reduces depressive-like symptoms such as helplessness and anhedonia (Djuric et al. 1999; Kalejaiye et al. 2011, 2012; Semba et al. 1998; Tizabi et al. 1999, 2000, 2009b, 2010).”
BackgroundSelf-citationDinarello, C. A. (1998) · PubMed · Cited by 203
Immune Disturbances during Major Depression: Upregulated Expression of Interleukin-2 Receptors
Maes, M., Bosmans, E., Suy, E., Vandervorst, C., De Jonckheere, C., & Raus, J. (2008) · Neuropsychobiology · doi:10.1159/000119472 · Cited by 200
Prolonged effect of an anesthetic dose of ketamine on behavioral despair
Yilmaz, A., Schulz, D., Aksoy, A., & Canbeyli, R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00693-1 · Cited by 199
Brynskov, J., Foegh, P., Pedersen, G., Ellervik, C., Kirkegaard, T., Bingham, A., & Saermark, T. (2002) · Gut · doi:10.1136/gut.51.1.37 · Cited by 198
Interferon-γ-Induced Conversion of Tryptophan: Immunologic and Neuropsychiatric Aspects
Wirleitner, B., Neurauter, G., Schrocksnadel, K., Frick, B., & Fuchs, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457179 · Cited by 197
Age‐dependent effects of chronic stress on brain plasticity and depressive behavior
Toth, E., Gersner, R., Wilf‐Yarkoni, A., Raizel, H., Dar, D. E., Richter‐Levin, G., Levit, O., & Zangen, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05642.x · Cited by 195
Temporal relationship between cigarette smoking and risk of Parkinson disease
Thacker, E. L., O’Reilly, E. J., Weisskopf, M. G., Chen, H., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256374.50227.4b · Cited by 194
Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity
Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T., & Akaike, A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00138-3 · Cited by 193
Dajas‐Bailador, F. A., Soliakov, L., & Wonnacott, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00725.x · Cited by 193
Adolescent smoking and depression: Which comes first?
Steuber, T. L., & Danner, F. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.04.010 · Cited by 193
Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious
Baron, J. A. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011533 · Cited by 192
Dopamine and alcoholism: neurobiological basis of ethanol abuse
Tupala, E., & Tiihonen, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.022 · Cited by 191
Prevalence of Dementia in an Urban Indian Population
Vas, C. J., Pinto, C., Panikker, D., Noronha, S., Deshpande, N., Kulkarni, L., & Sachdeva, S. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007852 · Cited by 191
Is impaired neurogenesis relevant to the affective symptoms of depression?
Sapolsky, R. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.012 · Cited by 188
Non-linear relationships in associations of depression and anxiety with alcohol use
RODGERS, B., KORTEN, A. E., JORM, A. F., JACOMB, P. A., CHRISTENSEN, H., & HENDERSON, A. S. (2000) · Psychological Medicine · doi:10.1017/s0033291799001865 · Cited by 188
Development of Major Depression After Treatment for Smoking Cessation
Tsoh, J. Y., Humfleet, G. L., Mu𮸼, R. F., Reus, V. I., Hartz, D. T., & Hall, S. M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.368 · Cited by 188
Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system
Xu, Y., Wang, Z., You, W., Zhang, X., Li, S., Barish, P. A., Vernon, M. M., Du, X., Li, G., & Pan, J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.013 · Cited by 186
Curcumin and neurodegenerative diseases: a perspective
Darvesh, A. S., Carroll, R. T., Bishayee, A., Novotny, N. A., Geldenhuys, W. J., & Van der Schyf, C. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.693479 · Cited by 184
Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 182
Prospective Study of Depression and the Risk of Heavy Alcohol Use in Women
Dixit, A. R., & Crum, R. M. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.751 · Cited by 181
Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells
Guan, Z. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00009-3 · Cited by 175
Prospective and retrospective reports of mood states before relapse to substance use.
Hodgins, D. C., el-Guebaly, N., & Armstrong, S. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.3.400 · Cited by 173
Interleukin-6 in the aging brain
Godbout, J. P., & Johnson, R. W. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.031 · Cited by 173
Tizabi, Y., Bhatti, B. H., Manaye, K. F., Das, J. R., & Akinfiresoye, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.052 · Cited by 173
Self-citationLynch, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00054-9 · Cited by 171
Cigarette Smoking and Psychiatric Comorbidity in Children and Adolescents
UPADHYAYA, H. P., DEAS, D., BRADY, K. T., & KRUESI, M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200211000-00010 · Cited by 171
The immunoregulatory effects of antidepressants
Maes, M. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.191 · Cited by 166
Chen, L.-W., Wang, Y.-Q., Wei, L.-C., Shi, M., & Chan, Y.-S. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707781387288 · Cited by 159
Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
Park, H.-J., Lee, P. H., Ahn, Y. W., Choi, Y. J., Lee, G., Lee, D., Chung, E. S., & Jin, B. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05636.x · Cited by 153
McKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 147
O'Sullivan, J. B., Ryan, K. M., Curtin, N. M., Harkin, A., & Connor, T. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570800967x · Cited by 146
Multiple roles for nicotine in Parkinson's disease
Quik, M., Huang, L. Z., Parameswaran, N., Bordia, T., Campos, C., & Perez, X. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.003 · Cited by 146
Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis
Gold, S. M., & Irwin, M. R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.008 · Cited by 146
Liu, Q., & Zhao, B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705653 · Cited by 145
Nicotine and inflammatory neurological disorders
Piao, W.-H., Campagnolo, D. I., Dayao, C. S., Lukas, R. J., Wu, J., & Shi, F. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.67 · Cited by 145
Anaesthetic-Related Neuroprotection: Intravenous or Inhalational Agents?
Schifilliti, D., Grasso, G., Conti, A., & Fodale, V. (2010) · CNS Drugs · doi:10.2165/11584760-000000000-00000 · Cited by 145
Gemma, C., Mesches, M. H., Sepesi, B., Choo, K., Holmes, D. B., & Bickford, P. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06114.2002 · Cited by 143
Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson??s Disease
Ross, G. W., & Petrovitch, H. (2001) · Drugs & Aging · doi:10.2165/00002512-200118110-00001 · Cited by 143
A RETROSPECTIVE STUDY OF SMOKING IN PARKINSON'S DISEASE1
Nefzger, M. D., QUADFASEL, F. A., & KARL, V. C. (1968) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120874 · Cited by 141
Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats
Semba, J., Mataki, C., Yamada, S., Nankai, M., & Toru, M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00477-0 · Cited by 140
Arora, V. K., Kuhad, A., Tiwari, V., & Chopra, K. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.012 · Cited by 140
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
Lakhan, S. E., & Kirchgessner, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-129 · Cited by 140
Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates
Quik, M., Parameswaran, N., McCallum, S. E., Bordia, T., Bao, S., McCormack, A. L., Kim, A., Tyndale, R. F., Langston, J. W., & Monte, D. A. D. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04078.x · Cited by 137
Cell pathology in mood disorders
Rajkowska, G. (2002) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2002.35228 · Cited by 135 · cited 2×
“in key brain regions such as prefrontal cortex and amygdala of patients with mood disorders causally links select reduction in brain volume to depression (Cotter et al. 2001; Rajkowska 2002; Rosso et al. 2005; Sheline et al. 1998).”
BackgroundCigarette smoking and Parkinson disease
Baumann, R. J., Jameson, H. D., McKean, H. E., Haack, D. G., & Weisberg, L. M. (1980) · Neurology · doi:10.1212/wnl.30.8.839 · Cited by 135
The putative neurodegenerative links between depression and Alzheimer's disease
Wuwongse, S., Chang, R. C., & Law, A. C. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.005 · Cited by 133
Liu, Y., Hu, J., Wu, J., Zhu, C., Hui, Y., Han, Y., Huang, Z., Ellsworth, K. R., & Fan, W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-98 · Cited by 133
Ethanol Inhibits NMDA Receptor‐Mediated Excitotoxicity in Rat Primary Neuronal Cultures
Chandler, L. J., Sumners, C., & Crews, F. T. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb00726.x · Cited by 127
Euphoriant effects of nicotine in smokers
Pomerleau, C. S., & Pomerleau, O. F. (1992) · Psychopharmacology · doi:10.1007/bf02247422 · Cited by 120
Stevens, T. R., Krueger, S. R., Fitzsimonds, R. M., & Picciotto, M. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10093.2003 · Cited by 119
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Chang, Y., Lee, J.-J., Hsieh, C., Hsiao, G., Chou, D., & Sheu, J. (2009) · Mediators of Inflammation · doi:10.1155/2009/705379 · Cited by 117
Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy
TAKAHASHI, S., Mizukami, K., Yasuno, F., & Asada, T. (2009) · Psychogeriatrics · doi:10.1111/j.1479-8301.2009.00292.x · Cited by 115
Ketamine Activates Cell Cycle Signaling and Apoptosis in the Neonatal Rat Brain
Soriano, S. G., Liu, Q., Li, J., Liu, J., Han, X., Kanter, J. L., Bajic, D., & Ibla, J. C. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d3e0c2 · Cited by 114
Effects of transderman nicotine on mood and sleep in nonsmoking major depresssed patients
Salín-Pascual, R. J., Galicia-Polo, L., Drucker-Colín, R., de la Fuente, J. R., Drucker-Colín, R., & Salín-Pascual, R. J. (1995) · Psychopharmacology · doi:10.1007/bf02246496 · Cited by 113
Cytokines role in neurodegenerative events
Viviani, B. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.022 · Cited by 109
Allard, J. S., Tizabi, Y., Shaffery, J. P., Trouth, C. O., & Manaye, K. F. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.06.004 · Cited by 108
Self-citationMcClernon, F. J., Hiott, F. B., Westman, E. C., Rose, J. E., & Levin, E. D. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0516-y · Cited by 106
Development of Major Depressive Disorder During Smoking-Cessation Treatment
Murphy, C., & Abrams, D. B. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1106 · Cited by 105
Hejmadi, M. V., Dajas‐Bailador, F., Barns, S. M., Jones, B. J., & Wonnacott, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00244-6 · Cited by 105
Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
Shi, F., Piao, W.-H., Kuo, Y., Campagnolo, D. I., Vollmer, T. L., & Lukas, R. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1730 · Cited by 105
The use of multi-target drugs in the treatment of neurodegenerative diseases
der Schyf, C. J. V. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.11.13 · Cited by 103
Teng, E., Ringman, J. M., Ross, L., Mulnard, R. A., Dick, M. B., Bartzokis, G., Davies, H. D., Galasko, D. R., Hewett, L., Mungas, D., et al. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318165dbae · Cited by 102
Memory impairments in healthy aging: Role of aging-induced microglial sensitization.
Barrientos, R. M., Frank, M. G., Watkins, L. R., & Maier, S. F. (2010) · PubMed · Cited by 101
Lavretsky, H., Zheng, L., Weiner, M. W., Mungas, D., Reed, B., Kramer, J. H., Jagust, W. J., Chui, H. C., & Mack, W. J. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2030 · Cited by 101
In vitro neuroprotective properties of the novel cholinergic channel activator (ChCA), ABT-418
Donnelly‐Roberts, D. L., Xue, I. C., Arnerić, S. P., & Sullivan, J. P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00063-7 · Cited by 101
Barton, B. E., Shortall, J., & Jackson, J. V. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.714-718.1996 · Cited by 100
Jarosik, J., Legutko, B., Unsicker, K., & Halbach, O. V. B. U. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.008 · Cited by 95
Ketamine Inhibits Endotoxin-induced Shock in Rats
Taniguchi, T., Shibata, K., & Yamamoto, K. (2001) · Anesthesiology · doi:10.1097/00000542-200110000-00022 · Cited by 94
Cigarette-Derived Nicotine is not a Medicine
Parrott, A. C. (2003) · The World Journal of Biological Psychiatry · doi:10.3109/15622970309167951 · Cited by 93
Shi, Y., Zhang, J., Mullin, M. J., Dong, B., Alberts, A. S., & Siminovitch, K. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803838 · Cited by 92
Ameliorative potential of quercetin against paracetamol-induced oxidative stress in mice blood
Singh, S., Kumar, M., Singh, R., Singh, S., & Chandra, K. (2011) · Toxicology International · doi:10.4103/0971-6580.84267 · Cited by 92
Diagnosis and Treatment of Depression Comorbid with Neurologic Disorders
Raskind, M. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.011 · Cited by 89
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 89
Self-citationThe Brain's Aging Immune System.
Streit, W. J., & Xue, Q. (2010) · PubMed · Cited by 87
Influence of nicotine on positive affect in anhedonic smokers
Cook, J. W., Spring, B. J., & McChargue, D. E. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0688-5 · Cited by 85
Manaye, K. F., Lei, D.-L., Tizabi, Y., Dávila‐García, M. I., Mouton, P. R., & Kelly, P. H. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.3.224 · Cited by 81
Self-citationNicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor
Cui, W.-Y., & Li, M. D. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9210-2 · Cited by 81
Resveratrol, map kinases and neuronal cells: might wine be a neuroprotectant?
Tredici, G., Miloso, M., Nicolini, G., Galbiati, S., Cavaletti, G., & Bertelli, A. A. A. (1999) · PubMed · Cited by 80
Antidepressant Effect of Ingested Nicotine in Female Rats of Flinders Resistant and Sensitive Lines
Djurić, V. J., Dunn, E., Overstreet, D. H., Dragomir, A., & Steiner, M. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00091-8 · Cited by 79
Maes, M. H. J., Meltzer, H. Y., Scharpé, S., Cooreman, W., Uyttenbroeck, W., Suy, E., Vandervorst, C., Calabrese, J. R., Raus, J., & Cosyns, P. R. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90081-q · Cited by 78
Chatterjee, P. K., Yeboah, M. M., Dowling, O., Xue, X., Powell, S. R., Al‐Abed, Y., & Metz, C. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035361 · Cited by 78
Resveratrol Protects Cortical Neurons against Microglia‐mediated Neuroinflammation
Zhang, F., Wang, H., Wu, Q., Lu, Y., Nie, J., Xie, X., & Shi, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4734 · Cited by 77
Conway, C. R., Sheline, Y. I., Chibnall, J. T., Bucholz, R. D., Price, J. L., Gangwani, S., & Mintun, M. A. (2011) · Brain stimulation · doi:10.1016/j.brs.2011.03.001 · Cited by 77
Inflammation and depression: Is there a causal connection with dementia?
E.Leonard, B., & Myint, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033243 · Cited by 76
Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF
Hauser, S. R., Getachew, B., Taylor, R. E., & Tizabi, Y. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.08.014 · Cited by 76
Self-citationNEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma, J. E., Stelt, O. V. D., & Gunning, W. B. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.6.522 · Cited by 76
Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
Gemma, C., Bachstetter, A. D., & Bickford, P. C. (2010) · Europe PMC (PubMed Central) · Cited by 74
Libert, C., Takahashi, N., Cauwels, A., Brouckaert, P., Bluethmann, H., & Fiers, W. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240945 · Cited by 73
Anti-inflammatory cytokine levels in patients with septic shock.
Kasai, T., Inada, K., Takakuwa, T., Yamada, Y., Inoue, Y., Shimamura, T., Taniguchi, S., Sato, S., Wakabayashi, G., & Endo, S. (1997) · PubMed · Cited by 71
Lynch, M. A. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)64006-3 · Cited by 71
Depressive Characteristics of FSL Rats
Tizabi, Y., Rezvani, A. H., Russell, L. T., Tyler, K. Y., & Overstreet, D. H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00236-7 · Cited by 70
Self-citationEffects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats
Tizabi, Y., Hauser, S. R., Tyler, K. Y., Getachew, B., Madani, R., Sharma, Y., & Manaye, K. F. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.024 · Cited by 66
Self-citationNicotine effects on affective response in depression-prone smokers
Spring, B. J., Cook, J. W., Appelhans, B. M., Maloney, A., Richmond, M., Vaughn, J., VanderVeen, J. W., & Hedeker, D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0977-7 · Cited by 66
Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study
Fritze, F., Ehrt, U., Hortobágyi, T., Ballard, C. G., & Aarsland, D. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000332016 · Cited by 63
Cited by
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET
Sandiego, C. M., Gallezot, J.-D., Pittman, B., Nabulsi, N., Lim, K., Lin, S.-F., Matuskey, D., Lee, J.-Y., O’Connor, K. C., Huang, Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511003112 · Cited by 356
Depression Among Older Adults: A 20-Year Update on Five Common Myths and Misconceptions
Haigh, E. A. P., Bogucki, O. E., Sigmon, S. T., & Blazer, D. G. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.06.011 · Cited by 316
Oxidative and nitrative stress in neurodegeneration
Cobb, C. A., & Cole, M. P. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.020 · Cited by 298
Zhang, J., Xie, X., Tang, M., Zhang, J., Zhang, B., Zhao, Q., Han, Y., Yan, W., Peng, C., & You, Z. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.07.012 · Cited by 150
Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00122 · Cited by 159
Metadata
- Authors
- Hurley, L. L., & Tizabi, Y.
- Venue
- Neurotoxicity Research
- Published
- 2012-08-16
- Volume
- 23
- Issue
- 2
- Pages
- 131-144
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- OpenAlex
- W2046970066
- Cited by
- 259
- References
- 240
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.